Covered recipient · General Payments record
AMANDA BRODEUR
General Payments · PY2023–2024
$888.75
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $781.15 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $226.84 | 3 |
| JAZZ PHARMACEUTICALS INC. | $189.15 | 3 |
| SK Life Science, Inc. | $162.95 | 2 |
| Alexion Pharmaceuticals, Inc. | $122.44 | 1 |
| Neurelis, Inc. | $32.57 | 1 |
| Neurocrine BioSciences, Inc. | $25.00 | 1 |
| Acerta Pharma LLC | $22.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $122.44 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110508378 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.20 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110516450 | CMS |
| JAZZ PHARMACEUTICALS INC. | $30.32 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150216226 | CMS |
| JAZZ PHARMACEUTICALS INC. | $138.81 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150216228 | CMS |
| JAZZ PHARMACEUTICALS INC. | $20.02 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150216230 | CMS |
| Neurelis, Inc. | $32.57 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145635288 | CMS |
| Neurocrine Biosciences, Inc. | $25.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150839852 | CMS |
| SK Life Science, Inc. | $130.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150806 | CMS |
| SK Life Science, Inc. | $32.50 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150818 | CMS |
| UCB, Inc. | $98.25 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245669 | CMS |
| UCB, Inc. | $93.82 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245673 | CMS |
| UCB, Inc. | $34.77 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245678 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.